Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Comparative Effects of Ribociclib and Palbociclib on Circulating and Tumor Infiltrating Myeloid Cells in Metastatic Breast Cancer Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05244434
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:36.930295+00:00
Published At
2022-06-09T00:00:00+00:00
Record Updated At
2022-06-09
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Advanced Breast Adenocarcinoma", "Advanced HER2-Negative Breast Carcinoma", "Anatomic Stage III Breast Cancer AJCC v8", "Anatomic Stage IIIA Breast Cancer AJCC v8", "Anatomic Stage IIIB Breast Cancer AJCC v8", "Anatomic Stage IIIC Breast Cancer AJCC v8", "Anatomic Stage IV Breast Cancer AJCC v8", "Hormone Receptor-Positive Breast Carcinoma", "Metastatic Breast Adenocarcinoma", "Metastatic HER2-Negative Breast Carcinoma", "Prognostic Stage III Breast Cancer AJCC v8", "Prognostic Stage IIIA Breast Cancer AJCC v8", "Prognostic Stage IIIB Breast Cancer AJCC v8", "Prognostic Stage IIIC Breast Cancer AJCC v8", "Prognostic Stage IV Breast Cancer AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-06-09"
protocolSection.identificationModule.nctId
"NCT05244434"
protocolSection.identificationModule.officialTitle
"Comparative Effects of Ribociclib and Palbociclib on Circulating and Tumor Infiltrating Myeloid Cells in Metastatic Breast Cancer Patients"
protocolSection.statusModule.overallStatus
"WITHDRAWN"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Advanced Breast Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Advanced HER2-Negative Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Anatomic Stage III Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Anatomic Stage IIIA Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Anatomic Stage IIIB Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Anatomic Stage IIIC Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Anatomic Stage IV Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Hormone Receptor-Positive Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Breast Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic HER2-Negative Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Prognostic Stage III Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Prognostic Stage IIIA Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Prognostic Stage IIIB Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Prognostic Stage IIIC Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Prognostic Stage IV Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.